Vertex (VRTX) and Molecular Templates (MTEM) Establish Pact to Discover, Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants
Go back to Vertex (VRTX) and Molecular Templates (MTEM) Establish Pact to Discover, Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants| (NASDAQ: MTEM) | Delayed: 0.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.11 | 52 Week High | $ | |||
| Open | $0.11 | 52 Week Low | $ | |||
| Day High | $0.11 | P/E | N/A | |||
| Day Low | $0.11 | EPS | $ | |||
| Volume | 2,578,809 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 466.79 +15.16 (3.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $451.63 | 52 Week High | $134.71 | |||
| Open | $455.65 | 52 Week Low | $73.31 | |||
| Day High | $468.18 | P/E | N/A | |||
| Day Low | $453.21 | EPS | $-1.98 | |||
| Volume | 2,034,572 | |||||

